Results 211 to 220 of about 96,214 (259)
Some of the next articles are maybe not open access.
Non-steroidal anti-inflammatory drugs
2013Several DSC studies have given a better understanding of the molecular mechanisms of interaction of many non-steroidal anti-inflammatory agents (NSAIDs), such as indomethacin, ibuprofen, naproxen, nimesulide, ketoprofen and oxicam drugs with cell membranes or with simplified phospholipid-based biomembrane models.The consequent changes in the ...
CARBONE, CLAUDIA +2 more
+4 more sources
Non-steroidal anti-inflammatory drugs and the heart
Heart, 2010Older patients are the most likely to use non-steroidal anti-inflammatory drugs (NSAIDs) and are at the highest risk of developing incident heart failure. In their paper published in this issue of Heart , von den Hondel et al 1 present imaging data from the Rotterdam Study highlighting the phenotypic manifestation of NSAID use on the heart, with ...
Ashish, Aneja, Michael E, Farkouh
openaire +2 more sources
Hypersensitivities to non-steroidal anti-inflammatory drugs
Expert Review of Clinical Immunology, 2014NSAIDs are the most commonly used medications worldwide and are responsible for almost 25% of adverse drug reactions. Such reactions can have different manifestations and can be immunologic or non-immunologic. The diagnosis is primarily based on the medical history, which can be difficult in patients receiving multiple medications. Because skin testing
Ahmad A, Mourad, Sami L, Bahna
openaire +2 more sources
Non-steroidal Anti-inflammatory Drugs and Hypertension
Cell Biochemistry and Biophysics, 2013Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used to alleviate pain of the patients who suffer from inflammatory conditions like rheumatoid arthritis, osteoarthritis, and other painful conditions like gout. This class of drugs works by blocking cyclooxgenases which in turn block the prostaglandin production in the body.
Liuying, Zheng, Xinping, Du
openaire +2 more sources
Non-steroidal Anti-Inflammatory Drugs and Melanoma
Current Pharmaceutical Design, 2012Inflammation is an important contributor to the development and progression of all human cancers. Inflammatory lipid metabolites, prostaglandins, formed from arachidonic acid by prostaglandin H synthases commonly called cyclooxygenases (COXs), bind to specific receptors that activate signaling pathways driving to the development and progression of ...
Virginia, Sanz-Motilva +2 more
openaire +2 more sources
Interactions of non-steroidal anti-inflammatory drugs
Baillière's Clinical Rheumatology, 1988As NSAIDs are commonly used in patients receiving concomitant drug therapy, there is a risk of clinically significant drug interactions. Important interactions with NSAIDs involve one or both of two major mechanisms: pharmacokinetic (e.g. lithium, phenytoin and barbiturates) and pharmacodynamic (e.g. antihypertensive agents, diuretics). Prescription of
A L, Tonkin, L M, Wing
openaire +2 more sources
Non-Steroidal Anti-Inflammatory Drugs
Rheumatology, 1993Pre-clinical studies suggest that, whilst NSAIDs have similar anti-inflammatory efficacy, the potential for producing side effects varies widely between members of this class of therapeutic agents. The ways in which NSAIDs produce one of their most serious side effects, gastrointestinal damage, are outlined and consideration is given to ways of ...
openaire +2 more sources
Non-steroidal anti-inflammatory drugs
Medicine, 2016Non-steroidal anti-inflammatory drugs are widely available and a common component of overdose. Toxic effects are principally renal. At high doses, coma and hepatic injury are rarely reported. Mefenamic acid is notable as it causes convulsions, although these are usually short-lived. Treatment is to a large extent supportive.
Euan A. Sandilands, D Nicholas Bateman
openaire +1 more source
Non-steroidal anti-inflammatory drugs and cytotoxics
Cancer Treatment Reviews, 1979T J, Powles, J L, Millar
openaire +2 more sources
Intolerance to non-steroidal anti-inflammatory drugs
Therapies, 2016Ghozlane, Lakhoua +5 more
openaire +2 more sources